Synthaverse S.A. (WSE:SVE)
Poland · Delayed Price · Currency is PLN 2.820
+0.030 (1.08%)
Oct 15, 2026, 12:53 PM CET
Synthaverse Market Cap
Synthaverse has a market cap or net worth of 213.67 million as of October 14, 2026. It is the 29,761st most valuable company in the world and the 193rd biggest in Poland. Its market cap has decreased by 26.72% in one year.
Market Cap
213.67M
Enterprise Value
296.58M
Revenue
48.76M
Global Rank
Country Rank
#193 Poland
PE Ratio
n/a
ChartMarket Cap Chart
Since July 29, 2011, Synthaverse's market cap has increased from 144.00M to 213.67M, an increase of 48.38%. That is a compound annual growth rate of 2.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 213.67M | -17.28% |
| Dec 30, 2025 | 258.31M | -18.67% |
| Dec 30, 2024 | 317.63M | 5.87% |
| Dec 29, 2023 | 300.01M | -28.71% |
| Dec 30, 2022 | 420.86M | 45.25% |
| Dec 30, 2021 | 289.76M | -48.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 552.55M |
| Ryvu Therapeutics | 388.42M |
| Captor Therapeutics Spolka Akcyjna | 386.92M |
| Bioceltix | 382.83M |
| BIOTON | 326.28M |
| Molecure | 134.33M |
| Mabion | 128.81M |
| Poltreg | 120.70M |